Acute Acalculous Cholecystitis in Patients With Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Report of Two Cases
Abstract
 Although sunitinib is associated with a variety of adverse events,  			cases of sunitinib-related acute cholecystitis have rarely been  			reported. We herein report two cases of sunitinib-related acute  			acalculous cholecystitis in patients with clear cell renal cell  			carcinoma. In both cases, the gallbladder was surgically removed  			because it was difficult to improve the patient’s condition with the  cessation of  			sunitinib and non-surgical treatment only.   Attention must be paid to the possibility of sunitinib-related acute  cholecystitis, which, although uncommon, can be life-threatening.
J Clin Med Res. 2014;6(4):302-304
doi: http://dx.doi.org/10.14740/jocmr1850w
		J Clin Med Res. 2014;6(4):302-304
doi: http://dx.doi.org/10.14740/jocmr1850w
Keywords
Sunitinib; Clear cell renal cell carcinoma; Acute acalculous cholecystitis; Cholecystectomy; Adverse event
		



 
  
  
  
  
  Email this article
			Email this article